Renal liver-type fatty acid binding protein attenuates angiotensin II-induced renal injury

Hypertension

Volumn 60, Issue 4, 2012, Pages 973-980

  Ichikawa, Daisuke ^a   Kamijo Ikemori, Atsuko ^a   Sugaya, Takeshi ^a   Yasuda, Takashi ^a   Hoshino, Seiko ^a   Igarashi Migitaka, Jyunko ^a   Hirata, Kazuaki ^a   Kimura, Kenjiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

angiotensin II; hypertension; L type fatty acid binding protein; oxidative stress; tubulointerstitial damage

Indexed keywords

ANGIOTENSIN II; FATTY ACID BINDING PROTEIN; HUMAN LIVER TYPE FATTY ACID BINDING PROTEIN; LYSINE; MONOCYTE CHEMOTACTIC PROTEIN 1; N (HEXANOYL)LYSINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HUMAN; KIDNEY INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; CHEMOKINE CCL2; FATTY ACID-BINDING PROTEINS; KIDNEY; MICE; MICE, TRANSGENIC; NEPHROSCLEROSIS; OXIDATIVE STRESS;

EID: 84866561988     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.199828     Document Type: Article

References (16)

1. Hu C, Kang BY, Megyesi J, Kaushal GP, Safrstein RL, Mehta JL. Deletion of LOX-1 attenuates renal injury following angiotensin II infusion. Kidney Int. 2009;76:521-527.
2. Mori T, Cowley AW Jr. Angiotensin II-NAD(P)H oxidase-stimulated superoxide modifes tubulovascular nitric oxide cross-talk in renal outer medulla. Hypertension. 2003;42:588-593.
3. Maatman RG, van de Westerlo EM, van Kuppevelt TH, Veerkamp JH. Molecular identifcation of the liver-and the heart-type fatty acid-binding proteins in human and rat kidney: use of the reverse transcriptase poly-merase chain reaction. Biochem J. 1992;288(pt 1):285-290.
4. Wang G, Gong Y, Anderson J, Sun D, Minuk G, Roberts MS, Burczynski FJ. Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells. Hepatology. 2005;42:871-879.
5. Simon TC, Roth KA, Gordon JI. Use of transgenic mice to map cis-acting elements in the liver fatty acid-binding protein gene (Fabpl) that regulate its cell lineage-specifc, differentiation-dependent, and spatial patterns of expression in the gut epithelium and in the liver acinus. J Biol Chem. 1993;268:18345-18358.
6. Ito S, Nagasawa T, Abe M, Mori T. Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res. 2009;32:115-121.
7. Johnson RJ, Gordon KL, Giachelli C, Kurth T, Skelton MM, Cowley AW Jr. Tubulointerstitial injury and loss of nitric oxide synthases parallel the development of hypertension in the Dahl-SS rat. J Hypertens. 2000;18:1497-1505.
8. Mori T, Cowley AW Jr. Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats. Hypertension. 2004;43:752-759.
9. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfeld P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205-251.
10. Kamijo A, Sugaya T, Hikawa A, Okada M, Okumura F, Yamanouchi M, Honda A, Okabe M, Fujino T, Hirata Y, Omata M, Kaneko R, Fujii H, Fukamizu A, Kimura K. Urinary excretion of fatty acid-binding protein refects stress overload on the proximal tubules. Am J Pathol. 2004;165:1243-1255.
11. Matsui K, Kamijo-Ikemorif A, Sugaya T, Yasuda T, Kimura K. Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity. Am J Pathol. 2011;178:1021-1032.
12. Yokoyama T, Kamijo-Ikemori A, Sugaya T, Hoshino S, Yasuda T, Kimura K. Urinary excretion of liver type fatty acid binding protein accurately refects the degree of tubulointerstitial damage. Am J Pathol. 2009;174:2096-2106.
13. Kamijo-Ikemori A, Sugaya T, Sekizuka A, Hirata K, Kimura K. Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid binding protein transgenic mice. Nephrol Dial Transplant. 2009;24:788-800.
14. Navar LG. Renal autoregulation: perspectives from whole kidney and single nephron studies. Am J Physiol. 1978;234:F357-370.
15. Kato Y, Mori Y, Makino Y, Morimitsu Y, Hiroi S, Ishikawa T, Osawa T. Formation of Nε-(hexanonyl)lysine in protein exposed to lipid hydroperoxide: a plausible marker for lipid hydroperoxide-derived protein modif-cation. J Biol Chem. 1999;274:ε20414.
16. Kamijo-Ikemori A, Sugaya T, Matsui K, Yokoyama T, Kimura K. Roles of human liver type fatty acid binding protein in kidney disease clarifed using hL-FABP chromosomal transgenic mice. Nephrology. 2011;16:539-544.